4,890
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

The diagnosis and management of CMV colitis in IBD patients shows high practice variation: a national survey among gastroenterologists

ORCID Icon, , , , &
Pages 1321-1326 | Received 17 Mar 2022, Accepted 06 Jun 2022, Published online: 30 Jun 2022

References

  • Römkens TEH, Bulte GJ, Nissen LHC, et al. Cytomegalovirus in inflammatory bowel disease: a systematic review. World J Gastroenterol. 2016;22(3):1321–1330.
  • Zhang WX, Ma CY, Zhang JG, et al. Effects of cytomegalovirus infection on the prognosis of inflammatory bowel disease patients. Exp Ther Med. 2016;12(5):3287–3293.
  • Hendler SA, Barber GE, Okafor PN, et al. Cytomegalovirus infection is associated with worse outcomes in inflammatory bowel disease hospitalizations nationwide. Int J Colorectal Dis. 2020;35(5):897–903.
  • Cohen S, Martinez-Vinson C, Aloi M, et al. Cytomegalovirus infection in pediatric severe ulcerative Colitis-A multicenter study from the pediatric inflammatory bowel disease Porto group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Pediatr Infect Dis J. 2018;37(3):197–201.
  • Jones A, McCurdy JD, Loftus EV Jr, et al. Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus. Clin Gastroenterol Hepatol. 2015;13(5):949–955.
  • Shukla T, Singh S, Tandon P, et al. Corticosteroids and thiopurines, but not tumor necrosis factor antagonists, are associated with cytomegalovirus reactivation in inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2017;51(5):394–401.
  • Beswick L, Ye B, van Langenberg DR. Toward an algorithm for the diagnosis and management of CMV in patients with colitis. Inflamm Bowel Dis. 2016;22(12):2966–2976.
  • Siegmund B. Cytomegalovirus infection associated with inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2017;2(5):369–376.
  • Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis. 2010;16(9):1620–1627.
  • Kucharzik T, Ellul P, Greuter T, et al. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021;15(6):879–913.
  • Lamb CA, Kennedy NA, Raine T, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106.
  • Lichtenstein GR. New ACG guideline for the management of Crohn's disease. Gastroenterol Hepatol. 2018;14(8):451.
  • Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114(3):384–413.
  • Turner D, Ruemmele FM, Orlanski-Meyer E, et al. Management of paediatric ulcerative colitis, part 2: acute severe colitis-an evidence-based consensus guideline from the European Crohn's and colitis organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;67(2):292–310.
  • van der Sloot KWJ, Voskuil MD, Visschedijk MC, et al. Latent cytomegalovirus infection does not influence long-term disease outcomes in inflammatory bowel disease, but is associated with later onset of disease. Scand J Gastroenterol. 2020;55(8):891–896.
  • Suzuki H, Kato J, Kuriyama M, et al. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol. 2010;16(10):1245–1251.
  • Yang H, Zhou W, Lv H, et al. The association between CMV viremia or endoscopic features and histopathological characteristics of CMV colitis in patients with underlying ulcerative colitis. Inflammatory Bowel Dis. 2017;23(5):814–821.
  • Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006;101(12):2857–2865.
  • Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011;106(11):2001–2008.
  • Pillet S, Williet N, Pouvaret A, et al. Distribution of cytomegalovirus DNA load in the inflamed colon of ulcerative colitis patients. Am J Gastroenterol. 2016;111(3):439–441.
  • Kim JW, Boo SJ, Ye BD, et al. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. J Crohn's Colitis. 2014;8(7):693–701.
  • Tandon P, James P, Cordeiro E, et al. Diagnostic accuracy of blood-based tests and histopathology for cytomegalovirus reactivation in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2017;23(4):551–560.
  • Turner D, Travis SP, Griffiths AM, et al. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD working group of ESPGHAN. Am J Gastroenterol. 2011;106(4):574–588.
  • Herfarth HH, Long MD, Rubinas TC, et al. Evaluation of a non-invasive method to detect cytomegalovirus (CMV)-DNA in stool samples of patients with inflammatory bowel disease (IBD): a pilot study. Dig Dis Sci. 2010;55(4):1053–1058.
  • Magdziak A, Szlak J, Mroz A, et al. A stool test in patients with active ulcerative colitis helps exclude cytomegalovirus disease. Scand J Gastroenterol. 2020;55(6):664–670.
  • Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50(10):1129–1136.